Cargando…

Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action

[Image: see text] Screening of 25 analogs of Ebselen, diversified at the N-aromatic residue, led to the identification of the most potent inhibitors of Sporosarcina pasteurii urease reported to date. The presence of a dihalogenated phenyl ring caused exceptional activity of these 1,2-benzisoselenazo...

Descripción completa

Detalles Bibliográficos
Autores principales: Macegoniuk, Katarzyna, Tabor, Wojciech, Mazzei, Luca, Cianci, Michele, Giurg, Mirosław, Olech, Kamila, Burda-Grabowska, Małgorzata, Kaleta, Rafał, Grabowiecka, Agnieszka, Mucha, Artur, Ciurli, Stefano, Berlicki, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923736/
https://www.ncbi.nlm.nih.gov/pubmed/36661843
http://dx.doi.org/10.1021/acs.jmedchem.2c01799
_version_ 1784887777221935104
author Macegoniuk, Katarzyna
Tabor, Wojciech
Mazzei, Luca
Cianci, Michele
Giurg, Mirosław
Olech, Kamila
Burda-Grabowska, Małgorzata
Kaleta, Rafał
Grabowiecka, Agnieszka
Mucha, Artur
Ciurli, Stefano
Berlicki, Łukasz
author_facet Macegoniuk, Katarzyna
Tabor, Wojciech
Mazzei, Luca
Cianci, Michele
Giurg, Mirosław
Olech, Kamila
Burda-Grabowska, Małgorzata
Kaleta, Rafał
Grabowiecka, Agnieszka
Mucha, Artur
Ciurli, Stefano
Berlicki, Łukasz
author_sort Macegoniuk, Katarzyna
collection PubMed
description [Image: see text] Screening of 25 analogs of Ebselen, diversified at the N-aromatic residue, led to the identification of the most potent inhibitors of Sporosarcina pasteurii urease reported to date. The presence of a dihalogenated phenyl ring caused exceptional activity of these 1,2-benzisoselenazol-3(2H)-ones, with K(i) value in a low picomolar range (<20 pM). The affinity was attributed to the increased π–π and π–cation interactions of the dihalogenated phenyl ring with αHis323 and αArg339 during the initial step of binding. Complementary biological studies with selected compounds on the inhibition of ureolysis in whole Proteus mirabilis cells showed a very good potency (IC(50) < 25 nM in phosphate-buffered saline (PBS) buffer and IC(90) < 50 nM in a urine model) for monosubstituted N-phenyl derivatives. The crystal structure of S. pasteurii urease inhibited by one of the most active analogs revealed the recurrent selenation of the Cys322 thiolate, yielding an unprecedented Cys322-S–Se–Se chemical moiety.
format Online
Article
Text
id pubmed-9923736
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-99237362023-02-14 Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action Macegoniuk, Katarzyna Tabor, Wojciech Mazzei, Luca Cianci, Michele Giurg, Mirosław Olech, Kamila Burda-Grabowska, Małgorzata Kaleta, Rafał Grabowiecka, Agnieszka Mucha, Artur Ciurli, Stefano Berlicki, Łukasz J Med Chem [Image: see text] Screening of 25 analogs of Ebselen, diversified at the N-aromatic residue, led to the identification of the most potent inhibitors of Sporosarcina pasteurii urease reported to date. The presence of a dihalogenated phenyl ring caused exceptional activity of these 1,2-benzisoselenazol-3(2H)-ones, with K(i) value in a low picomolar range (<20 pM). The affinity was attributed to the increased π–π and π–cation interactions of the dihalogenated phenyl ring with αHis323 and αArg339 during the initial step of binding. Complementary biological studies with selected compounds on the inhibition of ureolysis in whole Proteus mirabilis cells showed a very good potency (IC(50) < 25 nM in phosphate-buffered saline (PBS) buffer and IC(90) < 50 nM in a urine model) for monosubstituted N-phenyl derivatives. The crystal structure of S. pasteurii urease inhibited by one of the most active analogs revealed the recurrent selenation of the Cys322 thiolate, yielding an unprecedented Cys322-S–Se–Se chemical moiety. American Chemical Society 2023-01-20 /pmc/articles/PMC9923736/ /pubmed/36661843 http://dx.doi.org/10.1021/acs.jmedchem.2c01799 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Macegoniuk, Katarzyna
Tabor, Wojciech
Mazzei, Luca
Cianci, Michele
Giurg, Mirosław
Olech, Kamila
Burda-Grabowska, Małgorzata
Kaleta, Rafał
Grabowiecka, Agnieszka
Mucha, Artur
Ciurli, Stefano
Berlicki, Łukasz
Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
title Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
title_full Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
title_fullStr Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
title_full_unstemmed Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
title_short Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action
title_sort optimized ebselen-based inhibitors of bacterial ureases with nontypical mode of action
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923736/
https://www.ncbi.nlm.nih.gov/pubmed/36661843
http://dx.doi.org/10.1021/acs.jmedchem.2c01799
work_keys_str_mv AT macegoniukkatarzyna optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT taborwojciech optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT mazzeiluca optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT ciancimichele optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT giurgmirosław optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT olechkamila optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT burdagrabowskamałgorzata optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT kaletarafał optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT grabowieckaagnieszka optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT muchaartur optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT ciurlistefano optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction
AT berlickiłukasz optimizedebselenbasedinhibitorsofbacterialureaseswithnontypicalmodeofaction